Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).
Le X, Patel JD, Shum E, Baik C, Sanborn RE, Shu CA, Kim C, Fidler MJ, Hall R, Elamin YY, Tu J, Blumenschein G, Zhang J, Gibbons D, Gay C, Mohindra NA, Chae Y, Boumber Y, Sabari J, Santana-Davila R, Rogosin S, Herzberg B, Creelan B, Pellini B, Tanvetyanon T, Heeke S, Hernandez M, Gray JE, Saltos A, Heymach JV. Le X, et al. Among authors: boumber y. J Clin Oncol. 2024 Oct 8:JCO2400533. doi: 10.1200/JCO.24.00533. Online ahead of print. J Clin Oncol. 2024. PMID: 39378386
Musashi-2 (MSI2) regulation of DNA damage response in lung cancer.
Bychkov I, Deneka A, Topchu I, Pangeni R, Ismail A, Lengner C, Karanicolas J, Golemis E, Makhov P, Boumber Y. Bychkov I, et al. Among authors: boumber y. Res Sq [Preprint]. 2024 Apr 11:rs.3.rs-4021568. doi: 10.21203/rs.3.rs-4021568/v1. Res Sq. 2024. PMID: 38659828 Free PMC article. Preprint.
Musashi-2 (MSI2) regulation of DNA damage response in lung cancer.
Bychkov I, Deneka A, Topchu I, Pangeni RP, Lengner C, Karanicolas J, Golemis EA, Makhov P, Boumber Y. Bychkov I, et al. Among authors: boumber y. bioRxiv [Preprint]. 2023 Jun 14:2023.06.13.544756. doi: 10.1101/2023.06.13.544756. bioRxiv. 2023. PMID: 37398283 Free PMC article. Preprint.
Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer.
Bychkov I, Topchu I, Makhov P, Kudinov A, Patel JD, Boumber Y. Bychkov I, et al. Among authors: boumber y. Cancers (Basel). 2023 Apr 28;15(9):2529. doi: 10.3390/cancers15092529. Cancers (Basel). 2023. PMID: 37173995 Free PMC article.
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry.
Bai N, Adeshina Y, Bychkov I, Xia Y, Gowthaman R, Miller SA, Gupta AK, Johnson DK, Lan L, Golemis EA, Makhov PB, Xu L, Pillai MM, Boumber Y, Karanicolas J. Bai N, et al. Among authors: boumber y. Res Sq [Preprint]. 2023 Jan 10:rs.3.rs-2395172. doi: 10.21203/rs.3.rs-2395172/v1. Res Sq. 2023. PMID: 36711552 Free PMC article. Preprint.
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry.
Bai N, Adeshina Y, Bychkov I, Xia Y, Gowthaman R, Miller SA, Gupta AK, Johnson DK, Lan L, Golemis EA, Makhov PB, Xu L, Pillai MM, Boumber Y, Karanicolas J. Bai N, et al. Among authors: boumber y. bioRxiv [Preprint]. 2023 Jan 10:2023.01.09.523326. doi: 10.1101/2023.01.09.523326. bioRxiv. 2023. PMID: 36711508 Free PMC article. Preprint.
53 results